evodiamine has been researched along with Body Weight in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Atanasov, AG; Dirsch, VM; Heiß, EH; Hou, X; Malainer, C; Wang, K; Wang, L | 1 |
Liu, L; Ni, H; Ren, F; Ren, J; Shen, T; Wei, H; Wei, J; Xu, S; Zhou, X | 1 |
Chen, K; Lei, Q; Shi, J; Yan, J; Yang, D; Zhang, Y; Zhao, J; Zhao, X | 1 |
Hoshikuma, K; Kamiya, T; Kizaki, M; Kobayashi, Y; Nakano, Y; Yokoo, Y | 1 |
4 other study(ies) available for evodiamine and Body Weight
Article | Year |
---|---|
Evodiamine Lowers Blood Lipids by Up-Regulating the PPARγ/ABCG1 Pathway in High-Fat-Diet-Fed Mice.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily G, Member 1; Bile Acids and Salts; Body Weight; Diet, High-Fat; Lipids; Liver; Mice; Plant Extracts; PPAR gamma; Quinazolines | 2021 |
Combination of berberine and evodiamine inhibits intestinal cholesterol absorption in high fat diet induced hyperlipidemic rats.
Topics: Administration, Oral; Animals; Apolipoprotein B-48; Berberine; Body Weight; Cholesterol, LDL; Coptis; Diet, High-Fat; Drug Combinations; Evodia; Gene Expression Regulation; Hyperlipidemias; Hypolipidemic Agents; Intestinal Absorption; Lipid Metabolism; Liver; Male; Membrane Transport Proteins; Quinazolines; Rats; Rats, Sprague-Dawley; Sitosterols; Sterol O-Acyltransferase; Sterol O-Acyltransferase 2; Triglycerides | 2017 |
Intragastric administration of evodiamine suppresses NPY and AgRP gene expression in the hypothalamus and decreases food intake in rats.
Topics: Agouti-Related Protein; Animals; Appetite Regulation; Arcuate Nucleus of Hypothalamus; Body Weight; Dose-Response Relationship, Drug; Down-Regulation; Feeding Behavior; Gene Expression Regulation; Hypothalamus; Leptin; Male; Neuropeptide Y; Plant Extracts; Quinazolines; Rats; Rats, Sprague-Dawley; RNA, Messenger | 2009 |
Capsaicin-like anti-obese activities of evodiamine from fruits of Evodia rutaecarpa, a vanilloid receptor agonist.
Topics: Adipose Tissue; Animals; Anti-Obesity Agents; Body Temperature; Body Weight; Capsaicin; Cholesterol; Fatty Acids, Nonesterified; Fruit; Japan; Lipid Metabolism; Lipolysis; Liver; Male; Medicine, East Asian Traditional; Mice; Mice, Inbred C3H; Obesity; Phytotherapy; Plant Extracts; Plants, Medicinal; Quinazolines; Rats; Rats, Sprague-Dawley; Receptors, Drug; Rutaceae; Triglycerides | 2001 |